BioPharm America 2014: Interview with Roger Pomerantz, Seres Health

July 7, 2015
Roger Pomerantz, President and CEO of Seres Health, a 2014 FierceBiotech Fierce 15 winning company, shares the vision of his company and their pursuit of developing drugs to treat diseases of the microbiome, including metabolic, infectious and inflammatory. Seres' approach to microbiomics could potentially change how physicians treat infectious disease. Find more videos and articles at http://www.partnering360.com/insight For more information on BioPharm America, visit our webpage: http://www.ebdgroup.com/bpa/index.php
Previous Video
BIO-Europe 2014: Interview with Christian Hordo, Genentech
BIO-Europe 2014: Interview with Christian Hordo, Genentech

For Genentech, partnering early is the ideal. Christian Hordo of Genentech discusses how the company's scie...

Next Video
BioPharm America 2014: Interview with Eric Halioua, Promethera Biosciences
BioPharm America 2014: Interview with Eric Halioua, Promethera Biosciences

Eric Halioua, CEO of Promethera Biosciences, speaks with partnering360:Insight on their cell therapy produc...